Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susan Abu-absi currently holds 265,487 shares of Aura Biosciences, Inc. (AURA), valued at approximately $0. This represents their equity stake as Chief Operating Officer.
Based on SEC Form 4 filings, Susan Abu-absi has been a net neutral trader of AURA stock. They have purchased $0 and sold $0 worth of shares.
Susan Abu-absi's most recent insider trade was on Sep 1, 2026, when they sold 265,487 shares at $0.00 per share.
Susan Abu-absi serves as Chief Operating Officer at Aura Biosciences, Inc. (AURA). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Susan Abu-absi holds the position of Chief Operating Officer at Aura Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Susan Abu-absi has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Susan Abu-absi was on Sep 1, 2026, when they purchased $0 worth of AURA shares. This transaction involved 265,487 shares at N/A per share.
Susan Abu-absi currently owns 265,487 shares of Aura Biosciences, Inc. (AURA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susan Abu-absi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susan Abu-absi has 2 Form 4 filings on record as an insider at Aura Biosciences, Inc..
Set alerts for Susan Abu-absi and 40,000+ other insiders.